One Week of Oral Camostat Versus Placebo in Non-Hospitalized Adults with Mild-to-Moderate COVID-19: A Randomized Controlled Phase 2 Trial

By sjmartinez • June 7, 2023

Jilg N, Chew KW, Giganti MJ, Daar ES, Wohl DA, Javan AC, Kantor A, Moser C, Coombs RW, Neytman G, Hoover K, Jana A, Hart PA, Greninger AL, Szurgot B, Eron JJ, Currier JS, Hughes MD, Smith DM, Li JZ; ACTIV-2/A5401 Study Team. One Week of Oral Camostat Versus Placebo in Non-Hospitalized Adults with Mild-to-Moderate COVID-19: A Randomized Controlled Phase 2 Trial. Clin Infect Dis. 2023 Jun 5:ciad342. doi: 10.1093/cid/ciad342. Epub ahead of print. PMID: 37279602.

Tags: camostat, covid-19, Infectious Diseases, outpatient, phase 2, Publications, SARS-CoV-2

Co-circulation of Crimean-Congo hemorrhagic fever virus and spotted fever group Rickettsia in cattle and ticks from cattle in Kosovo

Italiya J, Hrazdilová K, Celina SS, Nekudova P, Obonyom TA, Robaj A, Cerny J, Modry D, Hensley LE, Rimoin AW, Zurek L. Co-circulation of Crimean-Congo[...]

Methicillin-resistant Staphylococcus aureus

Parsons JB, Westgeest AC, Conlon BP, Harbarth S, Howden BP, Kim YS, King HA, Lambregts MMC, Miller LG, Patel R, Wang M, Fowler VG Jr.[...]

Cefadroxil as Oral Transitional Therapy for Gram-Positive Bacteremia With or Without Non-Vertebral Osteomyelitis: A Multicenter Retrospective Cohort Study

Clark DC, Baden R, Banerjee J, Bedrossian R, Chute H, Davar K, Deng D, Donnelly M, Fernandez D, Goodman R, Gordon H, Harris E, Hutcheon[...]